These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6992699)

  • 1. Antiviral mechanisms of action.
    Smith RA; Sidwell RW; Robins RK
    Annu Rev Pharmacol Toxicol; 1980; 20():259-84. PubMed ID: 6992699
    [No Abstract]   [Full Text] [Related]  

  • 2. Viral encoded enzymes of nucleic acid metabolism and their role in the development of antiviral agents.
    Shugar D
    Prog Clin Biol Res; 1982; 102 Pt C():127-38. PubMed ID: 6132398
    [No Abstract]   [Full Text] [Related]  

  • 3. Prospects for the design of new antiviral molecules: a chemist's view.
    Walker RT
    J Antimicrob Chemother; 1984 Aug; 14 Suppl A():119-26. PubMed ID: 6490578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral drugs. Mode of action and chemotherapy of viral infections of man.
    Becker Y
    Monogr Virol; 1976; 11():1-130. PubMed ID: 768754
    [No Abstract]   [Full Text] [Related]  

  • 5. The antiviral activity and mechanism of action of (S)-[3-hydroxy-2-(phosphonomethoxy)propyl] (HPMP) nucleosides.
    Magee WC; Evans DH
    Antiviral Res; 2012 Nov; 96(2):169-80. PubMed ID: 22960154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of nucleoside, oligonucleotide and polynucleotide analogues as antiviral agents.
    De Clercq E
    Nucleic Acids Symp Ser; 1982; (11):203-6. PubMed ID: 6191285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleoside analogues with clinical potential in antivirus chemotherapy. The effect of several thymidine and 2'-deoxycytidine analogue 5'-triphosphates on purified human (alpha, beta) and herpes simplex virus (types 1, 2) DNA polymerases.
    Ruth JL; Cheng YC
    Mol Pharmacol; 1981 Sep; 20(2):415-22. PubMed ID: 6272095
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antiviral chemotherapy: mechanisms of action, evaluation of activity, resistance and future developments].
    Agut H; Fillet AM; Huraux JM
    Pathol Biol (Paris); 1993 Oct; 41(8 Pt 2):770-6. PubMed ID: 8309719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular and herpesvirus polymerases: their significance for chemotherapy.
    Müller WE; Falke D
    Adv Ophthalmol; 1979; 38():187-96. PubMed ID: 230715
    [No Abstract]   [Full Text] [Related]  

  • 10. Viral-associated and induced enzymes.
    Kit S
    Pharmacol Ther B; 1979; 4(3):501-85. PubMed ID: 89675
    [No Abstract]   [Full Text] [Related]  

  • 11. Potential mechanisms of action of antiviral agents.
    Prusoff WH; Goz B
    Fed Proc; 1973 Jun; 32(6):1679-87. PubMed ID: 4122954
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug therapy: antiviral agents (second of two parts).
    Hirsch MS; Swartz MN
    N Engl J Med; 1980 Apr; 302(17):949-53. PubMed ID: 6244492
    [No Abstract]   [Full Text] [Related]  

  • 13. Viral and host-cell protein kinases: enticing antiviral targets and relevance of nucleoside, and viral thymidine, kinases.
    Shugar D
    Pharmacol Ther; 1999; 82(2-3):315-35. PubMed ID: 10454209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational design of polymerase inhibitors as antiviral drugs.
    Oberg B
    Antiviral Res; 2006 Sep; 71(2-3):90-5. PubMed ID: 16820225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase.
    Furuta Y; Komeno T; Nakamura T
    Proc Jpn Acad Ser B Phys Biol Sci; 2017; 93(7):449-463. PubMed ID: 28769016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between virus and antiviral compounds in the host cell.
    Harmenberg J
    Med Biol; 1984; 62(6):299-303. PubMed ID: 6099858
    [No Abstract]   [Full Text] [Related]  

  • 17. Properties of herpesvirus-specific thymidine kinase, DNA polymerase and DNase and their implication in the development of specific antiherpes agents.
    Cheng YC; Hoffmann PJ; Ostrander M; Grill S; Caradonna S; Tsou J; Chen JY; Gallagher MR; Flanagan TD
    Adv Ophthalmol; 1979; 38():173-86. PubMed ID: 230714
    [No Abstract]   [Full Text] [Related]  

  • 18. [Target of developing the new anti-influenza virus reagents].
    Toyoda T
    Nihon Rinsho; 2003 Nov; 61(11):1980-6. PubMed ID: 14619442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism and antiviral activity of ribavirin.
    Parker WB
    Virus Res; 2005 Feb; 107(2):165-71. PubMed ID: 15649562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymidine kinase mutations conferring acyclovir resistance in herpes simplex type 1 recombinant viruses.
    Sergerie Y; Boivin G
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3889-92. PubMed ID: 16982796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.